Agreement for the commercialization of pharmaceutical products in Taiwan

From http://www.luqaventures.com/news.php (in English)

Hong Kong based company LUQA and Catalan company Laboratorios SALVAT, S.A. have reached an agreement for the commercialization of pharmaceutical product Cetraxal Plus in Taiwan. LUQA is a specialty company devoted to the commercialization of pharmaceutical products in the East Asia emerging markets, whereas Laboratorios SALVAT, S.A. is a renowned company that has been commercializing their products, like Cetraxal Plus, for more than 20 years on international markets.

[caption id="" align="aligncenter" width="331" caption="Cetraxal Plus (Image from LUQA website)"][/caption]

Pharmaceutical Catalan group Uriach enters Chinese market

From http://www.expansion.com/2011/02/17/catalunya/1297978427.html (in Spanish)

Pharmaceutical Catalan group Uriach has decided to enter the Chinese market through an alliance with a local partner which has not been disclosed. With this agreement, Uriach will have its first facilities abroad, which will add to those existing in Palau-solità i Plegamans and Sant Fost de Campsentelles. Another pharmaceutical company with a local Chinese partner is Esteve, which opened his second production plant in October 2010.